Quantcast

Latest FDA Stories

2014-06-04 23:00:22

Author Samuel S. Epstein has written a truly intriguing read in ‘Criminal Indifference of the FDA to Cancer Prevention’. CHICAGO (PRWEB) June 05, 2014 The FDA is trusted by the public to ensure that the foods and drugs used and manufactured are of good quality and danger-free. Sadly though, the FDA has had many inconsistencies through the years. In “Criminal Indifference of the FDA to Cancer Prevention”, author Samuel S. Epstein, M.D. has created a truly intriguing read that shows...

2014-06-04 20:22:03

Persistent gender inequity at FDA has led to 26 approved drugs for men, and ZERO for women WASHINGTON, June 4, 2014 /PRNewswire-USNewswire/ -- Highlighting a persistent gender inequity at the Food and Drug Administration regarding the approval of treatments for the most common forms of sexual dysfunction, a diverse group of women's health and research organizations today launched Even the Score, a new advocacy campaign created to serve as a voice for American women who believe that it's time...

2014-06-04 12:29:54

LOS ANGELES, June 4, 2014 /PRNewswire-USNewswire/ -- A recent article published in Molecular Imaging and Biology, the journal of the World Molecular Imaging Society, discusses a streamlined and cost-effective approach to obtain Investigational New Drug (IND) approvals from the Food and Drug Administration (FDA) for positron emission tomography (PET) imaging probes. The article "de-mystifies" the process and provides a straightforward description on how to achieve approval for an...

2014-06-03 23:10:00

Firm's M1 Capnography Mask obtains US market authorization with support from Emergo Group. Seattle, WA (PRWEB) June 03, 2014 Seattle based Monitor Mask Inc., has obtained US Food and Drug Administration 510(k) premarket notification clearance for the M1 Capnography Mask. The M1 Capnography Mask is a disposable oxygen face mask designed to monitor patient breathing by directly interfacing with a sidestream capnograph. Capnography, or exhaled CO2 monitoring, is increasingly recognized...

2014-06-03 23:05:30

On June 2, the FDA announced that certain lots of Soliris (eculizumab) Concentrated Solution for IV Infusion, by Alexion, are recalled due to visible particulates. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. (PRWEB) June 03, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for Soliris (eculizumab). The FDA...

2014-06-03 23:03:26

Regulating Biosimilars; Stem Cell Therapies and 3-D Printing; Increasing FDA Oversight Overseas Washington (PRWEB) June 03, 2014 Hot topics facing drug development and access—evolving regulatory guidelines for novel therapies, a shifting pharmaceutical research and development (R&D) landscape, and U.S. regulatory challenges at home and overseas—will be discussed by global innovators at the DIA 2014 50th Annual Meeting, to be held at the San Diego Convention Center from June 15 to...

2014-06-03 23:02:32

The Firm is representing numerous clients in GranuFlo Lawsuits, all of which allege the use of GranuFlo or NaturaLyte dialysis concentrates caused serious, and sometimes deadly, heart injuries. New York, NY (PRWEB) June 03, 2014 As GranuFlo lawsuits (http://www.thegranuflolawsuit.com/ ) filed in the wake of the 2012 recall of GranuFlo and NaturaLyte dialysis concentrates continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that products included in a second NaturaLyte...

2014-06-03 23:01:42

Panel at DIA Annual Meeting to Explore Evidentiary Standards and Regulatory Hurdles Washington (PRWEB) June 03, 2014 A forum on “FDA Programs to Encourage Innovation: Maximizing the Opportunities and Confronting the Challenges of New Product Development” will take place on June 17 at 10:30 a.m. as part of the DIA 2014 50th Annual Meeting at the San Diego Convention Center. As FDA promotes its initiatives to add flexibility to the drug approval process, scholars scrutinize their...

2014-06-03 16:25:04

HORSHOLM, Denmark, June 3, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced the hiring of senior level management in preparation for potential U.S. commercialization of Envarsus(®) XR (tacrolimus extended-release tablets) an investigational new drug under FDA review for the prevention of organ rejection in adult kidney transplant patients. Key points: -- Envarsus( )XR is an extended release formulation of tacrolimus being designed for once-daily...

2014-06-03 12:37:09

SILVER SPRING, Md., June 3, 2014 /PRNewswire-USNewswire/ -- FDA's Read the Label Youth Outreach Campaign is an exciting initiative that challenges kids (ages 9 to 13) to "get their food facts first" by using the Nutrition Facts Label to make healthy food choices. Read the Label campaign materials enable parents and caregivers to help kids use this important tool. To view the multimedia assets associated with this release, please click:...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related